ClinConnect ClinConnect Logo
Search / Trial NCT02636959

A Postoperative Study on HVSI vs LVSI Treatment of Chronic Rhinosinusitis

Launched by UNIVERSITY OF BRITISH COLUMBIA · Dec 17, 2015

Trial Information

Current as of July 21, 2025

Unknown status

Keywords

ClinConnect Summary

BACKGROUND: Chronic Rhinosinusitis (CRS) is a common inflammatory condition of the upper respiratory tract lasting more than 8 to 12 weeks. Major symptoms include facial congestion/fullness, facial pain/pressure, nasal obstruction/blockage, purulent nasal drainage, and reduction or loss of smell. The diagnosis must include two major symptoms and either endoscopic evidence of polyps, edema or mucopurulent discharge from the middle meatus and/or CT changes in the mucosa of sinuses or osteomeatal complexes.

CRS has an estimated prevalence of 5% in the Canadian population, and up to 16% in som...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Documented diagnosis of unilateral or bilateral CRS
  • Documented failed medical treatment of CRS
  • 18 to 65 years of age
  • Planned ESS for the treatment of CRS
  • Able to read and understand English
  • Exclusion Criteria:
  • Pregnant
  • Cystic Fibrosis
  • Diagnosed immotile cilia syndrome
  • Diagnosed immunodeficiency syndrome
  • Diagnosed fungal sinusitis
  • Sinonasal tumours or obstructive lesions

About University Of British Columbia

The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.

Locations

Vancouver, British Columbia, Canada

Patients applied

0 patients applied

Trial Officials

Arif Janjua, MD

Principal Investigator

Vancouver Coastal Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials